Review Services
EAC Services
Endpoint Adjudication Committee (EAC)
Secure independent evaluation and adjudication of complex clinical trial endpoints. Ensure accurate and timely determinations of whether participants meet safety and efficacy endpoints in drug and device trials with Advarra’s worldwide network of medical experts.
Key Features
- Independent adjudication
- Largest global network of experts
- Food and Drug Administration (FDA) and European Medicines Agency (EMA) compliance
- Rapid delivery
- 20+ years experience
Overview
Medical Expertise
Advarra’s network includes 1,500+ statisticians, medical professionals, and research experts, ensuring reliable adjudication of clinical trial endpoints.
Global Trial Support
We provide services for trials worldwide, covering all therapeutic areas, including oncology, CNS, and precision medicine.
Enhanced Data Security
Your trial data is protected by advanced data protection technologies, compliant with the Health Insurance Portability and Accountability Act (HIPAA), the General Data Protection Regulation (GDPR), the Personal Information Protection and Electronic Documents Act (PIPEDA), and FDA 21 CFR Part 11.
Regulatory Compliance
Our services comply with U.S. FDA and EU EMA guidelines, ensuring your trial meets regulatory expectations for independent review.
Custom Adjudication Plans
We develop tailored adjudication plans in collaboration with your clinical and medical teams, ensuring they fit the complexity of your trial.
Flexible Platform
Our platform is audit-ready and integrates seamlessly with electronic data capture systems and Digital Imaging and Communications in Medicine (DICOM) tools.
Support for every therapeutic area and trial design, including:
- Oncology
- Medical devices
- Precision medicine
- Gene therapy
- Complex endpoints
- Central nervous system
- Decentralized trial modalities
- Worldwide sites
